Who Supplies Diclofenac? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Diclofenac exports, with 1007+ registered manufacturers shipping to buyers across 173+ countries — yet a handful of companies dominate the shipments. LINCOLN PHARMACEUTICALS LTD holds the largest share at 14.7% (export value: $53.6M). Close behind, COMBITIC GLOBAL CAPLET PRIVATE LIMITED (8.6%, $31.4M). RUBICON RESEARCH PRIVATE LIMITED (5.8%, $21.1M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Diclofenac? Top Manufacturers & Their Buyers
Flow of Diclofenac from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Diclofenac Supplier Network — Key Market Intelligence
The Diclofenac export market from India is led by LINCOLN PHARMACEUTICALS LTD, which alone commands a 14.7% share, shipping $53.6M worth of product across 179 shipments. The second-largest exporter, COMBITIC GLOBAL CAPLET PRIVATE LIMITED, contributes $31.4M (8.6%) to the overall market. Combined, the top two suppliers alone account for 23.4% of all Diclofenac exports, indicating a relatively concentrated supply base.
Across all 1007 tracked manufacturers, the total Diclofenac export value stands at $363.9M from 15.0K shipments. The market average shipment value is $24.3K. The single largest buyer relationship in terms of trade value is HEKO PHARMACY LTD, receiving $43.9M worth of product.
The combined buyer network spans 25 named purchasing companies, including HEKO PHARMACY LTD, UNIVERSAL CO. LTD., PLANET PHARMA, GENERICS & SPECIALIT, SHAMS NOORI PHARMA TRADING COMPANY and 20 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1LINCOLN PHARMACEUTICALS LTD
LINCOLN PHARMACEUTICALS LTD is the first-largest Diclofenac exporter from India, with a market share of 14.7% and a total export value of $53.6M across 179 shipments. Their average shipment value of $299.6K is above the market average of $24.3K, suggesting premium or bulk contract pricing.
LINCOLN PHARMACEUTICALS LTD serves 5 named buyers in our database. HEKO PHARMACY LTD is the dominant customer, accounting for 81.8% of this supplier's tracked business. Top customers include:
• HEKO PHARMACY LTD — $43.9M across 147 shipments (81.8% of this supplier's total exports)
• UNIVERSAL CO. LTD. — $5.9M across 20 shipments (11.1% of this supplier's total exports)
• PLANET PHARMA — $2.0M across 7 shipments (3.8% of this supplier's total exports)
• GENERICS & SPECIALIT — $974.3K across 3 shipments (1.8% of this supplier's total exports)
• TO THE ORDER — $798.6K across 3 shipments (1.5% of this supplier's total exports)
Key Insight: LINCOLN PHARMACEUTICALS LTD's per-shipment value of $299.6K is 1135% above the market average of $24.3K, consistent with large-order contracts or value-added formulations.
2COMBITIC GLOBAL CAPLET PRIVATE LIMITED
COMBITIC GLOBAL CAPLET PRIVATE LIMITED is the second-largest Diclofenac exporter from India, with a market share of 8.6% and a total export value of $31.4M across 216 shipments. Their average shipment value of $145.2K is above the market average of $24.3K, suggesting premium or bulk contract pricing.
COMBITIC GLOBAL CAPLET PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• SHAMS NOORI PHARMA TRADING COMPANY — $14.1M across 97 shipments (45.0% of this supplier's total exports)
• SFS PHARM LLC — $13.9M across 96 shipments (44.3% of this supplier's total exports)
• OOO SMARTPHARMO — $2.9M across 20 shipments (9.3% of this supplier's total exports)
• WADAN KATAWAZ TRADIN — $340.5K across 2 shipments (1.1% of this supplier's total exports)
• MUHABAT LIMITED — $94.6K across 1 shipments (0.3% of this supplier's total exports)
Key Insight: COMBITIC GLOBAL CAPLET PRIVATE LIMITED's per-shipment value of $145.2K is 499% above the market average of $24.3K, consistent with large-order contracts or value-added formulations.
3RUBICON RESEARCH PRIVATE LIMITED
RUBICON RESEARCH PRIVATE LIMITED is the third-largest Diclofenac exporter from India, with a market share of 5.8% and a total export value of $21.1M across 93 shipments. Their average shipment value of $226.6K is above the market average of $24.3K, suggesting premium or bulk contract pricing.
RUBICON RESEARCH PRIVATE LIMITED serves 5 named buyers in our database. RELIABLE HEALTHCARE LOGISTICS LLC is the dominant customer, accounting for 67.8% of this supplier's tracked business. Top customers include:
• RELIABLE HEALTHCARE LOGISTICS LLC — $14.3M across 63 shipments (67.8% of this supplier's total exports)
• TRIFLUENT PHARMA — $2.6M across 12 shipments (12.6% of this supplier's total exports)
• EVERSANA LIFE SCIENC — $1.9M across 9 shipments (9.2% of this supplier's total exports)
• SPYKA WHOLESALE INC — $1.8M across 8 shipments (8.5% of this supplier's total exports)
• INA PHARMACEUTICS IN — $407.0K across 2 shipments (1.9% of this supplier's total exports)
Key Insight: RUBICON RESEARCH PRIVATE LIMITED's per-shipment value of $226.6K is 834% above the market average of $24.3K, consistent with large-order contracts or value-added formulations.
4CAPLIN POINT LABORATORIES LIMITED
CAPLIN POINT LABORATORIES LIMITED is the fourth-largest Diclofenac exporter from India, with a market share of 4.0% and a total export value of $14.6M across 310 shipments. Their average shipment value of $47.3K is above the market average of $24.3K, suggesting premium or bulk contract pricing.
CAPLIN POINT LABORATORIES LIMITED serves 5 named buyers in our database. NUEVOS ETICOS NEOETHICALS, S.A. is the dominant customer, accounting for 69.7% of this supplier's tracked business. Top customers include:
• NUEVOS ETICOS NEOETHICALS, S.A. — $10.2M across 216 shipments (69.7% of this supplier's total exports)
• NEOETHICALS, S.A, — $2.3M across 48 shipments (15.5% of this supplier's total exports)
• NUEVOS ETICOS NEOETHICALS, S.A. — $927.2K across 20 shipments (6.3% of this supplier's total exports)
• DROGUERIA SAIMED S.A — $862.2K across 18 shipments (5.9% of this supplier's total exports)
• DROGUERIA SAIMED SA — $376.5K across 8 shipments (2.6% of this supplier's total exports)
Key Insight: CAPLIN POINT LABORATORIES LIMITED's per-shipment value of $47.3K is 95% above the market average of $24.3K, consistent with large-order contracts or value-added formulations.
5CIPLA LIMITED
CIPLA LIMITED is the fifth-largest Diclofenac exporter from India, with a market share of 3.3% and a total export value of $11.8M across 1.1K shipments. Their average shipment value of $11.2K is below the market average of $24.3K, reflecting a high-volume, competitive pricing strategy.
CIPLA LIMITED serves 5 named buyers in our database. CIPLA USA INC UPS SUPPLY CHAIN SOLU is the dominant customer, accounting for 98.5% of this supplier's tracked business. Top customers include:
• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $11.7M across 1.0K shipments (98.5% of this supplier's total exports)
• ALJABAL DRUGS AND ME — $64.3K across 6 shipments (0.5% of this supplier's total exports)
• BREATHEFREE LANKA PR — $38.9K across 3 shipments (0.3% of this supplier's total exports)
• PHARMASCIENCE INC — $38.6K across 3 shipments (0.3% of this supplier's total exports)
• PHYSICIANS PHARMACEU — $35.8K across 3 shipments (0.3% of this supplier's total exports)
Key Insight: CIPLA LIMITED operates with high shipment frequency (1.1K shipments) at a per-shipment value of $11.2K, indicating a broad distribution network with many smaller, regular orders.
6TROIKAA PHARMACEUTICALS LIMITED
TROIKAA PHARMACEUTICALS LIMITED is the fifth-largest Diclofenac exporter from India, with a market share of 1.8% and a total export value of $6.4M across 471 shipments. Their average shipment value of $13.6K is below the market average of $24.3K, reflecting a high-volume, competitive pricing strategy.
TROIKAA PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• PLANET PHARMA — $2.1M across 153 shipments (32.6% of this supplier's total exports)
• PLANET PHARMA — $1.9M across 139 shipments (29.5% of this supplier's total exports)
• PLANET PHARMA — $1.2M across 88 shipments (18.8% of this supplier's total exports)
• LLC SERENE PHARMA — $726.4K across 53 shipments (11.3% of this supplier's total exports)
• ABACUS PHARMA A LIMI — $504.0K across 37 shipments (7.8% of this supplier's total exports)
Key Insight: TROIKAA PHARMACEUTICALS LIMITED operates with high shipment frequency (471 shipments) at a per-shipment value of $13.6K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Diclofenac Flows
Once Diclofenac leaves the manufacturing plants of companies like LINCOLN PHARMACEUTICALS LTD and COMBITIC GLOBAL CAPLET PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $363.9M. United States absorbs the largest share at 25.1% ($91.2M), followed by Tanzania (13.3%) and Uzbekistan (6.1%).
In United States — the top destination — named importers include CIPLA USA INC UPS SUPPLY CHAIN SOLU, RELIABLE HEALTHCARE LOGISTICS LLC, AIM RX 3PL, LLC. In Tanzania, key buyers are HEKO PHARMACY LTD.
This geographic spread reflects Diclofenac's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Diclofenac Go? Top Importing Countries & Their Buyers
Trade flow of Diclofenac exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Diclofenac imports from India, with a total trade value of $91.2M across 1,311 shipments — representing a 25.1% share of all Diclofenac exports. The average shipment value of $69.6K is above the global average of $24.3K, indicating high-value procurement contracts or branded formulations. This market is served by 8 tracked buyers.
Named Diclofenac importers in United States: CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest buyer, accounting for 22.5% ($20.5M) of this market's total imports.
• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $20.5M (22.5% of United States's total)
• RELIABLE HEALTHCARE LOGISTICS LLC — $14.4M (15.8% of United States's total)
• AIM RX 3PL, LLC — $7.2M (7.9% of United States's total)
Key Insight: United States's per-shipment average of $69.6K (187% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Diclofenac imports from India.
2Tanzania
Tanzania ranks as the second-largest destination for Diclofenac imports from India, with a total trade value of $48.6M across 54 shipments — representing a 13.3% share of all Diclofenac exports. The average shipment value of $899.5K is above the global average of $24.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Diclofenac importers in Tanzania: HEKO PHARMACY LTD is the largest buyer, accounting for 92.8% ($45.1M) of this market's total imports.
• HEKO PHARMACY LTD — $45.1M (92.8% of Tanzania's total)
Key Insight: Tanzania's per-shipment average of $899.5K (3608% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Tanzania is a key market for Diclofenac imports from India.
3Uzbekistan
Uzbekistan ranks as the third-largest destination for Diclofenac imports from India, with a total trade value of $22.3M across 45 shipments — representing a 6.1% share of all Diclofenac exports. The average shipment value of $495.6K is above the global average of $24.3K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Diclofenac importers in Uzbekistan: SFS PHARM LLC is the largest buyer, accounting for 62.8% ($14.0M) of this market's total imports.
• SFS PHARM LLC — $14.0M (62.8% of Uzbekistan's total)
• OOO SMARTPHARMO — $3.0M (13.2% of Uzbekistan's total)
• SHAYANA FARM LLC — $2.7M (12.1% of Uzbekistan's total)
Key Insight: Uzbekistan's per-shipment average of $495.6K (1943% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Uzbekistan is a key market for Diclofenac imports from India.
4Ghana
Ghana ranks as the fourth-largest destination for Diclofenac imports from India, with a total trade value of $19.7M across 0 shipments — representing a 5.4% share of all Diclofenac exports. The average shipment value of $19.7M is above the global average of $24.3K, indicating high-value procurement contracts or branded formulations.
Key Insight: Ghana's per-shipment average of $19.7M (80931% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Ghana is a key market for Diclofenac imports from India.
5France
France ranks as the fifth-largest destination for Diclofenac imports from India, with a total trade value of $19.2M across 228 shipments — representing a 5.3% share of all Diclofenac exports. The average shipment value of $84.2K is above the global average of $24.3K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Diclofenac importers in France: PLANET PHARMA is the largest buyer, accounting for 57.4% ($11.0M) of this market's total imports.
• PLANET PHARMA — $11.0M (57.4% of France's total)
• CENTRE SPECIALITES PHARMACEUTIQUES — $3.9M (20.3% of France's total)
Key Insight: France's per-shipment average of $84.2K (247% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
France is a key market for Diclofenac imports from India.
People Also Ask — Diclofenac Supplier & Trade Network
Who are the top suppliers of Diclofenac from India?+
Which companies buy Diclofenac from Indian manufacturers?+
Where does Diclofenac exported from India go?+
What is the market share of the top Diclofenac supplier from India?+
What is the average shipment value for Diclofenac exports from India?+
Is Diclofenac manufactured in India and exported globally?+
Which country imports the most Diclofenac from India?+
Who are the buyers of Diclofenac in Tanzania?+
How concentrated is the Diclofenac supplier market in India?+
How do I find verified buyers for Diclofenac in specific countries?+
Diclofenac Trade Network — Key Takeaways
- 1LINCOLN PHARMACEUTICALS LTD is India's dominant Diclofenac exporter with a 14.7% market share and $53.6M in total exports — making it the single most important sourcing entity in this market.
- 2The top 1007 suppliers collectively account for 38.2% of all tracked Diclofenac exports, with a combined trade value of $363.9M.
- 3United States is the largest destination market, absorbing 25.1% of India's Diclofenac exports ($91.2M). Tanzania (13.3%) and Uzbekistan (6.1%) follow.
- 4With 15.0K total shipments averaging $24.3K each, the Diclofenac export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include HEKO PHARMACY LTD, UNIVERSAL CO. LTD., SHAMS NOORI PHARMA TRADING COMPANY, SFS PHARM LLC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 173 countries
Network value: $363.9M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Diclofenac — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Diclofenac.
- 2.Flow Mapping: 1007 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 15,000 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 173 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
15,000 Verified Shipments
1007 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists